Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma.
Takuro YamaguchiKenichiro UemuraYoshiaki MurakamiNaru KondoNaoya NakagawaKenjiro OkadaShingo SeoEiso HiyamaShinya TakahashiTaijiro SuedaPublished in: Annals of surgical oncology (2020)
For the patients with PDAC, the presence of preoperative ctDNA was significantly associated poor OS, whereas postoperative ctDNA was not associated with poor survival. A positive change in ctDNA did not affect patients' survival.